Cellular senescence is a stable cell cycle arrest that limits the proliferation of pre-cancerous cells. Here we demonstrate that scaffold-attachment-factor A (SAFA) and the long noncoding RNA PANDA differentially interact with polycomb repressive complexes (PRC1 and PRC2) and the transcription factor NF-YA to either promote or suppress senescence. In proliferating cells, SAFA and PANDA recruit PRC complexes to repress the transcription of senescence-promoting genes. Conversely, the loss of SAFA-PANDA-PRC interactions allows expression of the senescence programme. Accordingly, we find that depleting either SAFA or PANDA in proliferating cells induces senescence. However, in senescent cells where PANDA sequesters transcription factor NF-YA and limits the expression of NF-YA-E2F-coregulated proliferation-promoting genes, PANDA depletion leads to an exit from senescence. Together, our results demonstrate that PANDA confines cells to their existing proliferative state and that modulating its level of expression can cause entry or exit from senescence.
C ellular senescence is a proliferative arrest triggered by potentially cancer-causing events and it thus limits the outgrowth of pre-cancerous cells 1 . The gene-regulatory programme that initiates and maintains this phenotype remains by-and-large elusive but generally involves the stable repression of proliferation-promoting genes regulated by the retinoblastoma/ E2F transcription factor complex 2 . Transcriptional regulation of E2F target genes is a highly complex process involving cooperation of E2F transcription factors with a large array of other promoter-specific transcription factors like CCAAT binding factor NF-YA 3, 4 or co-repressors including components of the RNAi machinery and histone methyl transferases among others 5 . Senescent cells also strongly de-repress senescenceenforcing genes such as CDKN1A (alias p21) and CDKN2A (alias p16), as well as a plethora of secretory factors and their receptors (for example, IL8, BMP2, WNT or MMP3), all of which are pivotal for the proper and timely execution of the senescence programme 1 . Many of the above genes are repressed in proliferating cells by polycomb repressor complexes (PRC) and accordingly, functional ablation of certain polycomb group (PcG) proteins induces a senescence arrest [6] [7] [8] [9] .
PcG proteins broadly assemble in two different multi-protein complexes: PRC1 and PRC2. Core components of PRC1 include the ubiquitin ligase RING1A/B, BMI1 (PCGF4), NSCP1 (PCGF1) and MEL18, whereas those of PRC2 include histone methyl transferase EZH2, EED and SUZ12, though it becomes increasingly clear that PRC complexes are heterogeneous with variable composition 10 . PRC1 catalyses mono-ubiquitination of lysine 119 on histone H2A (H2AK119 ub1 ), and together with PRC2, which catalyses trimethylation of lysine 27 on histone H3 (H3K27 me3 ), it creates an inactive chromatin environment to control cell-fate decisions 10, 11 . A central question is how PcG proteins are recruited to their cognate gene targets given their lack of an inherent DNA binding activity. Several mechanisms have been proposed [12] [13] [14] [15] and there is an increasing evidence that geneselective recruitment may be driven by the varying composition of PRCs 16 . More recently, nascent 17 and long noncoding (lnc) RNAs have been shown to direct PRCs to site-selected targets. LncRNAs modulate gene expression in multiple ways but few have been fully functionally characterized 18 . They may work as guides or modular chromatin scaffolds to recruit co-repressors or co-activators but may also operate as decoys as is the case for lncRNA PANDA, a lncRNA coregulated together with CDKN1A by tumour suppressor protein p53. For example, PANDA transiently sequesters transcription factor NF-YA to suppress its pro-apoptotic function during a DNA damage response 19 .
SAFA is a very abundant multimodular nuclear protein that is able to bind DNA and RNA including several classes of noncoding RNA [20] [21] [22] . It is involved in various transcriptional and posttranscriptional processes. Notably, it was shown to be instrumental for the deposition of lncRNA Xist and PRC2-mediated silent chromatin mark H3K27 me3 at the inactive X chromosome 20, 23, 24 . Yet, the precise role that SAFA has in most of these processes remains to be determined. We hypothesized that because of its intrinsic DNA-and RNA-binding activity, SAFA would naturally lend itself to operate as an adaptor molecule for DNA-RNA-protein interactions to regulate gene expression and given its implication in PRC-mediated H3K27 me3 deposition to regulate cell-fate decisions. Here we report a direct physical and functional association between SAFA and lncRNA PANDA with PRC1, PRC2 and transcription factor NF-YA in a cell-fate dependent manner. We provide evidence that SAFA and PANDA control chromatin access of PRCs and NF-YA to prosenescence and pro-proliferation target genes to regulate the cell cycle arrest associated with senescence.
Results SAFA depletion leads to the onset of cellular senescence. We previously performed comprehensive genome-wide gene expression profiling to identify genes that are differentially regulated in cellular senescence 5, 25, 26 . A number of genes have been shown to promote senescence upon loss of function 7, 25, 27, 28 . Among the genes that were consistently downregulated by at least 1.5-fold (P ¼ o0.01) in cells undergoing senescence was the scaffoldattachment-factor A (SAFA alias hnRNPU or SP120). To confirm our microarray results, we performed quantitative real-time PCR (qRT-PCR) and immunoblot analyses. Senescent cells induced either by replicative exhaustion (that is, replicative senescent, RS) or oncogenic Ras V12 (RAS) displayed a reduction in SAFA transcript (Fig. 1a ) and protein levels (Fig. 1b) . Thus, the downregulation of SAFA gene expression coincides with the onset of senescence induced by two different signals. To establish that a decreasing pool of SAFA directly leads to senescence, we targeted its expression by short hairpin interference in two normal, primary human diploid fibroblast strains, BJ (neonatal foreskin) and WI38 (fetal lung), using a scrambled control (shC) and two individual knock-down constructs against SAFA (shSAFA-1 and shSAFA-2). BJ and WI38 fibroblasts represent the two extremes in a spectrum of p53 or p53/Rb/CDKN2A-dependent senescence with BJ fibroblast senescence requiring solely the p53-(but not CDKN2A/Rb pathway) and WI38 senescence utilizing both p53 and CDKN2A/Rb tumour suppressor pathway(s) 29 . BJ and WI38 fibroblasts depleted for SAFA became fully senescent after 4-6 days as judged by a stable proliferative arrest ( Fig. 1c ; data for WI38 shown only for proliferation curves), an increase in cells staining positive for senescence-associated beta-galactosidase (SABG) (Fig. 1d) , CDKN1A ( Fig. 1e ) and senescence-associated heterochromatin foci (Fig. 1f) , a decrease in cells staining positive for proliferation marker Ki67 (Fig. 1g) , the appearance of dysmorphic nuclei as measured by lamin B1 (LB1) indirect immunostaining ( Fig. 1e) and repression of E2F-responsive genes such as AURKA, BRCA1, CCNB1, CCNA2, CDC2, CDC25C, CDK1, E2F1, MCM3 and TK1 (Supplementary Fig. 1 ). In addition, immunoblotting showed a decrease in Rb phosphorylation and LB1 protein levels (the latter being congruent with the observed malformation of the nuclear envelope; see Fig. 1e ) accompanied by a simultaneous increase in CDKN1A protein levels in SAFAdepleted (shSAFA) compared with control (shC) cells (Fig. 1h) . Together, these results argue that silencing of the SAFA expression is not merely associated with the senescence phenotype but actively contributes to it.
SAFA is a component of PRC1 and PRC2. As a first step towards an understanding as to how SAFA might be involved in senescence, we examined in an unbiased fashion whether SAFA has a predilection for certain chromatin states by performing a histone association assay 30 . All antibodies directed against posttranslational histone modifications precipitated their respective targets efficiently ( Supplementary Fig. 2a ) and we detected interactions between SAFA and active chromatin marks histone H3 trimethylated on lysine 4 (H3K4 me3 ), histone H3 trimethylated on lysine 36 (H3K36 me3 ), histone H3 acetylated on lysine 9 (H3K9 ac ) and histone H3 acetylated on lysine 18 (H3K18 ac ; Fig. 2a, lanes 2, 5, 8 and 9 ). We also observed a robust binding of SAFA to the PRC2-catalysed repressive histone mark H3K27 me3 (Fig. 2a, lane 4) and because PRC components are essential for the timely and proper execution of senescence [6] [7] [8] [9] , we tested the possibility that SAFA cooperates with PcG proteins first by performing co-immunoprecipitations in cells ectopically expressing either HA-tagged PRC1 component BMI1 (alias PCGF4), FLAG-tagged PRC2 core components EZH2 and SUZ12 or corresponding empty vectors. Overexpressed HA-BMI1 (Fig. 2b, left panels) , FLAG-EZH2, FLAG-SUZ12 (Fig. 2b , right panels) and endogenous SAFA (Fig. 2b , left and right panels) reciprocally co-immunoprecipitated each other demonstrating that SAFA interacts with these PcG proteins in vivo. To extend the physiological relevance for these interactions, we carried out co-immunoprecipitations between endogenous SAFA and PRC1 core subunits BMI1, RING1A and RING1B, as well as PRC2 core subunits EZH2 and SUZ12 in whole cell lysates prepared from low passage, proliferating BJ fibroblasts. As depicted in Fig. 2c and Supplementary Fig. 2b , a sub-fraction of SAFA specifically co-immunoprecipitated with all tested PcG proteins (compare lanes 1, 2, 3, 4, 5 with lanes 6 and 7). By contrast, SAFA did not interact with NSCP1 (alias PCGF1, Supplementary Fig. 2c ), which is the distinct determinant of a non-BMI1 containing PRC1 complex 16 . These results thus suggest that SAFA is part of a PRC1 complex that includes BMI1 and Ring1A/B but not NSCP1, which is congruent with the finding that PRC1 subcomplexes are distinguished by different PCGF family members 16 . We then used proximity-ligation assay (PLA) to visualize and quantify endogenous SAFA-SAFA, SAFA-BMI1 and SAFA-EZH2 interactions in proliferating fibroblasts 31 . As displayed in Fig. 2d (upper panels PLA) , we detected on average B3,100 SAFA-SAFA, B138 SAFA-BMI1 and B186 SAFA-EZH2 distinct PLA-foci/interactions, thus, only a small fraction of endogenous SAFA molecules is available for PRC interactions in a nucleus, which is corroborated further by classical indirect immunofluorescence analysis of SAFA/BMI1 and SAFA/EZH2 nuclear distribution (Fig. 2d lower panels IF) . Technical and biological controls showed that PLA was highly sensitive and very specific for interactions between endogenous proteins ( Supplementary Fig. 2d ). Next, we dissected which SAFA domains are necessary for optimal binding to PcG proteins. To this end, we assayed cell lysates from cells overexpressing FLAGtagged SAFAwt (wild-type), SAFADSAF (DNA-binding-deficient Supplementary Fig. 2e ) by coimmunoprecipitations with antibody to FLAG. The bound proteins were analysed by western blotting with antibodies against BMI1 and EZH2 serving as proxies for PRC1 and PRC2 core subunits. Both proteins co-immunoprecipitated very efficiently with SAFAwt and SAFADSPRY proteins (Fig. 2e , compare lanes 2 and 4). By contrast, the association of BMI1 and EZH2 with SAFADSAF or SAFADRGG was reduced by B2-5-fold (Fig. 2e , compare lane 2 with lanes 3 and 5). Together, these results provide ample evidence that SAFA can interact with BMI1-PRC1 and EZH2/SUZ12-PRC2 complexes and that its DNA as well as RNA-binding domains contribute to optimal complex formation.
SAFA regulates expression of PRC target genes. We next sought to determine the functional relevance of the interaction between SAFA and PRC complexes. A number of PRC response genes, notably CDKN1A, CDKN2A, IL6R, IL8, JUNB, DUSP4 and BMP2, were shown to encode important pro-senescence factors [32] [33] [34] [35] [36] [37] . Comparison of our list of genes upregulated in senescence 5 to two published lists of potential human PRC target genes 38, 39 showed that B7% of upregulated genes in senescence constitute potential PRC targets and that B24% of potential PRC targets are derepressed by at least 2-fold in senescence (Supplementary Fig. 3a and Supplementary Data). On the basis of our interaction study, we hypothesized that SAFA is required for proper transcriptional repression of PRC target genes. If so, silencing of SAFA expression should result in de-repression of PRC target genes. To test this hypothesis, we first assayed total RNA prepared from control siRNA (siC), siSAFA (siS)-, siBMI1 (siB)-, siEZH2 (siE)-transfected cells as well as from pre-senescent proliferating (PS) and RAS-senescent (S) BJ fibroblasts after 48 h of siRNA treatment by qRT-PCR for the expression status of selected PRC target genes upregulated in senescence (that is, DUSP4, CCNE1, WNT7B, CDKN1A, BMP2, DLX2 and CNIH3). SAFA expression was markedly decreased by a pool of two validated siRNAs 40 whereas the expression of PRC core components BMI1, RING1B, EZH2 and EED was unaffected by the transient knockdown treatment ( Fig. 3a and Supplementary Fig. 3b ). This analysis also revealed the de-repression of the selected PRC response genes by 2 to 9-fold in SAFA- (Fig. 3b ), BMI1-, EZH2-depleted ( Supplementary Fig. 3c,d ) and in senescent cells (Fig. 3c ) when compared with respective controls. The observed derepression was positively correlated with a strongly decreased occupancy of SAFA, EZH2, SUZ12, BMI1, RING1B, as well as PRC-catalysed inactive chromatin marks H3K27 me3 and H2AK119 ub1 at respective PRC target gene promoters as determined by chromatin immunoprecipitation followed by quantitative real-time PCR (qChIP-PCR, Fig. 3d and Supplementary Fig. 3e ). Since transient SAFA silencing did not affect BMI1, RING1B, EED or Ezh2 levels, the most plausible explanation for the decreased target gene occupancy of PRC components is that SAFA contributes to their recruitment in proliferating cells. Next, we examined whether the genomic binding of SAFA depends on PcG proteins by SAFA-qChIP-PCR in BMI1-and EZH2-depleted cells. As summarized in Fig. 3e , we found that neither silencing of BMI1 (siB) (upper panel) nor EZH2 (siE)(lower panel) impacted on SAFA presence at selected target genes. By contrast, BMI1 depletion affected H2AK119 ub1 (upper panel) and EZH2 depletion H3K27 me3 (lower panel) deposition at the interrogated targets. We thus conclude that SAFA gene target binding does not require intact BMI1-PRC1 and EZH2-PRC2 complexes. Congruent with the above results, we found the interaction between SAFA and BMI1, as well as SAFA and EZH2 to be impaired in cells undergoing oncogeneinduced senescence compared with controls already at a time point (day 2) when cells are in transit between the initial mitotic (day 1) and the senescence phase (day 6 and beyond) 25, 41 and EZH2 and BMI1 levels are not yet diminished as observed in the senescence phase ( Fig. 3f ; compare lane 1 with 4, 3 with 6, 7 with 10 and 9 with 12; Supplementary Fig. 3f,g ). By contrast, the interaction between SAFA and two known interactors, HP1 (ref. 40 ) and b-actin 42 , was unperturbed ( Fig. 3f ; compare lane 13 with 16, 15 with 18, 19 with 22 and 21 with 24) as was the binding between EZH2 and SUZ12, as well as BMI1 and RING1A in SAFA-silenced and senescent cells when compared with controls ( Supplementary Fig. 3h ). Next, we studied the effects of SAFA downregulation on global H3K27 me3 and H2AK119 ub1 levels. Knock-down of SAFA neither significantly affected the global cellular levels of H3K27 me3 nor H2AK119 ub1 congruent with published results 23 ( Supplementary Fig. 3i ). This observation is consistent with the idea that interference with SAFA function results in only gene-specific changes in H3K27 me3 or H2AK119 ub1 . Collectively, the above results support the notion that SAFA is required for efficient recruitment of BMI1-PRC1 and -PRC2 complexes to select senescence target genes to silence their expression in pre-senescent, proliferating cells. By contrast, in SAFA-depleted cells and in cells undergoing senescence, the BMI1-PRC1 EZH2-PRC2 complexes are displaced from chromatin, and these genes become de-repressed.
SAFA and PRCs negatively regulate CDKN1A and lncRNA PANDA. CDKN1A is a canonical transcriptional target gene of p53, PRC complexes 33 and SAFA (see Fig. 3b ). Its transcription is strongly induced in cells undergoing senescence and it has a critical role in the establishment of the senescence phenotype 1 . Recently, P53 was shown to positively co-regulate CDKN1A and lncRNA PANDA (hereafter termed PANDA) expression. The transcriptional start site (TSS) of PANDA was mapped B4.5 kbp upstream of the CDKN1A TSS and B2.5 kbp upstream of the major P53 response element 19 . Because SAFA is a repressor of CDKN1A in pre-senescent proliferating cells (see Fig. 3b ), we asked whether SAFA also represses PANDA expression in these cells. Indeed, PANDA transcript abundance was robustly increased B4-fold in SAFA (siS)-depleted cells when compared with respective controls (siC) and B4-10-fold in RAS and RS cells (Fig. 4a) . To map SAFA and PRC binding sites within the CDKN1A promoter more precisely, we performed SAFA-ChIP-PCR in nuclear lysates prepared from pre-senescent proliferating BJ fibroblasts with six primer pairs amplifying genomic regions that are located þ 324-676, þ 677-981, þ 1,335-1,688, þ 2,029-2,478, þ 3,141-3,558 and þ 4,149-4,525 bp upstream of the CDKN1A TSS. Apart from region þ 3,141-3,558, all other regions were identified previously as bona fide P53 promoter binding sites 43, 44 with the þ 4,149-4,525 region protruding into the PANDA gene. While SAFA and PcG proteins SUZ12, EZH2, BMI1 and RING1B co-occupied proximal CDKN1A promoter regions þ 324-676, þ 677-981 and distal region þ 4,149-4,525, only SAFA and PRC2 core components SUZ12 and EZH2 were enriched on the distal region þ 2,029-2,478, whereas regions þ 1,335-1,688 and þ 3,141-3,558 were negative for any binding (Fig. 4b) . To substantiate the direct physical association between SAFA and the ChIP-identified CDKN1A promoter regions, gelshift experiments were performed with purified recombinant GST-SAFA and GST proteins ( Supplementary Fig. 4 ). This analysis illustrated that GST-SAFA, but not GST, has the potential to bind specifically and autonomously to regions þ 324-676, þ 677-981, þ 4,149-4,525 and þ 2,029-2,478; but only weakly to þ 1,335-1,688 and þ 3,141-3,558, thus, confirming our above-shown ChIP results (Fig. 4c) . Next, we examined SAFA, EZH2, SUZ12, BMI1, RING1A/B, repressive chromatin marks H3K27 me3 and H3K9 me3 , as well as active chromatin marks H3K9 ac and H4K8 ac occupancies in SAFA-depleted and senescent cells within the CDKN1A promoter region þ 324-676 and the PANDA protruding region þ 4,149-4,525, respectively using SAFA- qChIP-PCR. Congruent with the above results, showing that SAFA and PRCs work as repressors of CDKN1A and PANDA, we found that, both in SAFA-silenced (siSAFA) (Fig. 4d) and in RAS-senescent cells (S) (Fig. 4e) , the presence of SAFA, EZH2, SUZ12, BMI1, RING1A/B, H3K27 me3 and H3K9 me3 was markedly decreased compared with controls (siC and PS, respectively), whereas the active chromatin marks H3K9 ac and H4K8 ac were enriched at the respective promoters. We conclude that SAFA and PRCs are negative co-regulators of CDKN1A and PANDA expression and that SAFA can associate autonomously with specific promoter regions. These data, thus, further corroborate the notion that SAFA constitutes a crucial factor regulating the access of PcG protein complexes to select senescence target genes in a sequence-specific fashion in pre-senescent proliferating cells. Finally, given the differential expression of PANDA in pre-senescent versus senescent cells, our data also point to a potential involvement of PANDA in senescence.
PANDA and SAFA reinforce their interactions with BMI1. SAFA binds to many different classes of regulatory noncoding RNAs 22 and its RGG domain is necessary for RNA interaction 21 . Moreover, lincRNA-p21 was shown to physically associate with the SAFA family member hnRNP-K to regulate transcription 45 . We therefore entertained the idea that SAFA and PANDA could physically and functionally interact to control gene expression. ARTICLE Indeed, endogenous PANDA RNA co-immunoprecipitated with SAFA in cellular lysates prepared from 293HEK cells (Fig. 5a) . Importantly, the interaction was not detected when an isogenic IgG antibody was used and in RNAse-treated samples excluding the presence of contaminating DNA. We then extended this study to cell lysates prepared from pre-senescent proliferating (PS) and senescent (S) fibroblasts. Here, we detected a robust and specific interaction between SAFA and PANDA, but not other lncRNAs such as TUG1 or MALAT1, in pre-senescent proliferating but not senescent cells (Fig. 5b) . qRT-PCR revealed that PANDA was present at B130 copies per nucleus in proliferating and B1,200 copies per nucleus in senescent fibroblasts ( Supplementary  Fig. 5a ). These numbers are intriguing given that we detected about 130 SAFA-BMI1 and 180 SAFA-EZH2 interactions in proliferating cells (see Fig. 2c ) indicating that PANDA may be primarily engaged in SAFA-BMI1 complexes. Next, we mapped the domains essential for this interaction by RIP in cells overexpressing SAFA FLAG-tagged wild-type and mutant constructs (see Fig. 2e and Supplementary Fig. 2e ) using FLAGspecific antibody followed by qRT-PCR and immunoblot. This analysis demonstrated that SAFA lacking the RGG RNA-binding domain (DRGG) was completely deficient for PANDA binding, and SAFA lacking the SAF DNA-binding domain (DSAF) had strongly reduced binding for PANDA (B3-fold). By contrast, SAFA lacking the SPRY domain (DSPRY) showed slightly increased binding to PANDA by B1.6-fold when compared with wild-type SAFA (Fig. 5c) . Recently, lincRNAs were shown to interact with several chromatin regulatory complexes 45 . We thus sought to determine whether or not PANDA modulates the interaction between SAFA and PRC1 and PRC2 core components. Indeed, BMI1 efficiently co-immunopreciptated PANDA while EZH2 was negative for binding, the latter being in line with published results 19 (Fig. 5d) . By contrast two lncRNAs, TUG1 and HOTAIR, that were shown to interact with EZH2, were positive while MALAT1 was negative for binding 46 . Remarkably, the interaction between SAFA and BMI1 was specifically perturbed by a pool of two validated PANDA siRNAs 19 (siP), but not by the respective siControl (siC; Fig. 5e , compare lanes 8 and 9), whereas the binding between SAFA and EZH2 was unaffected under both conditions (Fig. 5e, compare lanes 6 and 7) . Importantly, transient PANDA depletion did not alter expression levels of SAFA, EZH2 and BMI1 as shown by qRT-PCR analysis ( Supplementary Fig. 5b ) and the equal amounts of these proteins in siControl and siPANDA-treated cell extracts (Fig. 5e for SAFA, compare lanes 4 and 5; Supplementary Fig. 5c for EZH2 and BMI1). We next tested the effect of SAFA depletion on BMI1-PANDA interaction.
As shown in Fig. 5f , complex formation between BMI1 and PANDA was strongly reduced in SAFA-silenced (siSAFA) cells compared with controls (siC). This is consistent with our additional finding showing that the RNA-binding domain of SAFA is critical for optimal binding both to BMI1 as well as PANDA (see Figs 2e and 5c). We also note that the interaction between SAFA and other PcG proteins including SUZ12, RING1A and RING1B was entirely RNA-independent ( Supplementary  Fig. 5d ). Together, these data show that PANDA is an integral part of a BMI1-PRC1 complex and that, both, PANDA and SAFA reciprocally reinforce their affinity for BMI1. By contrast, SAFA binding to EZH2 and other PcG proteins is PANDA-and integrally RNA-independent. Thus, PANDA impacts BMI1-PRC1 rather than PRC2 function.
PANDA regulates PRC target gene and senescence entry. The aggregate of the above results prompted us to investigate whether or not PANDA regulates SAFA-BMI1-PRC1-mediated transcriptional repression. A recent study by Bracken et al. 39 identified a collection of genes that are de-repressed upon BMI1 depletion. Many of these genes are found de-repressed in senescent cells (Supplementary Data and Supplementary Fig. 6a ). We thus examined in siControl, siPANDA, siSAFA and siBMI1-treated proliferating BJ fibroblasts the expression status for a random selection of some of these genes (that is, BDNF, MT1G, IL8, BIRC3, JUNB and PELI1), plus for genes that we had already validated as being de-repressed in senescence and by BMI1 depletion (that is, DUSP4, CNIH3 and WNT7B; see Fig. 3b and Supplementary Fig. 3b ) and finally for some additional randomly picked PRC target genes that are upregulated in senescent cells (that is, CCNE1, PKP1, RASD1 and MMP3). As summarized in Fig. 6a and Supplementary Fig. 6b , siPANDA (siP), siSAFA (siS) and siBMI1-depletion (siB) led to a strong de-repression by B3 to 30-fold of MMP3, DUSP4, PKP1, JUNB, RASD1, MT1G, PELI1, BIRC3, CNIH3, BDNF, WNT7B, IL8 and CCNE1 compared with siControl (siC)-treated cells. Moreover, using qChIP-PCR, we could demonstrate that de-repression of PRCresponsive genes in PANDA-and SAFA-depleted cells led to a strong reduction in the physical presence of BMI1 (Fig. 6b ) and H2AK119 ub1 ( Supplementary Fig. 6c , compare lanes 7, 8 and 9) at respective target genes, which is comparable with what is observed in siBMI1-treated cells ( Supplementary Fig. 6d , compare lanes 9 and 10). Interestingly, PANDA silencing also induced a reduction of SAFA binding at interrogated promoter targets. This implies that, although SAFA has the potential to specifically and autonomously bind non-chromatized 'naked' DNA as used in the fully recombinant electrophoretic mobility shift assay (see Fig. 4c ), in a native chromatin environment, PANDA seems to impact the dynamics (either on or off rate) of SAFA binding and thus the effective residence time at any given gene target. The global level of H2AK119 ub1 was not altered in siPANDA-(siP) compared with siControl (siC)-treated cells indicating that depletion of PANDA akin to SAFA ( Supplementary Fig. 3f ) only leads to gene-specific and global changes in H2AK119 ub1 ( Supplementary Fig. 6e ). The above observations led us to examine if PANDA acts directly at PRC targets by employing chromatin-isolation by RNA purification (ChIRP) 47 followed by qRT-PCR (qCHIRP) (Fig. 6c) . To this end, we designed a set of 10 unique complementary oligonucleotides to PANDA RNA and as a negative control five complementary probes that target bacterial lacZ mRNA. In concordance with the notion that PANDA acts as a co-repressor at the same sites as PRCs in pre-senescent proliferating cells (PS), we could specifically pull down PANDA RNA and enrich for a selection of PRC target promoters with PANDA, but not lacZ probes, in these cells, whereas this failed in senescent (S) cells although we efficiently enriched for PANDA in these cells as well ( Supplementary Fig. 6f ). On the basis of the above data, we surmised that PANDA depletion could impact the proliferative potential of pre-senescent fibroblasts by destabilizing BMI1-PRC1, thus, leading to de-repression of pro-senescence PRC targets and an ensuing onset of senescence. Indeed, extended siRNA-mediated PANDA depletion induced a proliferative arrest in pre-senescent BJ fibroblasts within 4 days ( Fig. 6d ) with canonical features of senescence including increased SABG activity and decreased incorporation of 5-ethynyl-2 deoxyuridine (EdU) into DNA (Fig. 6e) , modest to strong upregulation of p53 and pro-senescence PRC targets CDKN1A (Fig. 6f) , DUSP4, JUNB (see Fig. 6a ), IL8 and CCNE1 ( Supplementary Fig. 6b ) and downregulation of cell cycle genes CCNE2, CCNA2, CDK1, CDK2, MCM3, PCNA, as well as of LB1 (Supplementary Fig. 6g ). Importantly, siPANDA-induced senescence neither occured in CDKN1A knock-out fibroblasts 48 ( Fig. 6g ) nor in PANDA and CDKN1A co-silenced cells indicating that CDKN1A constitutes a crucial downstream target for PANDA-dependent senescence ( Supplementary  Fig. 6h,i) . Collectively, our results indicate that PANDA, in conjunction with SAFA, is a transcriptional co-repressor of PRC target genes through recruitment of BMI1-PRC1 to respective promoters and an ensuing H2AK119 ubiquitination of the latter in pre-senescent proliferating cells. Moreover, our data show that PANDA levels are instrumental for cell-fate decisions since PANDA depletion in proliferating cells led to a senescent proliferative arrest by decomposition of the SAFA-PANDA-BMI1 complex and subsequent de-repression of the CDKN1A growth-inhibitory gene.
PANDA regulates NF-YA function and senescence exit. PANDA levels increased in senescent cells (see Fig. 4a ), whereas SAFA decreased (Fig. 1b) , and the interaction between PANDA and residual SAFA was reduced in senescent cells (see Fig. 5b ). The questions that naturally arise is: where does PANDA go in senescent cells and how may PANDA aid in the implementation of senescence? Recently, PANDA was shown to function as a molecular decoy for the transcription factor NF-YA to inhibit activation of an apoptotic gene expression programme. Aside from controlling a number of pro-apoptotic genes, NF-YA also co-regulates, in unison with E2Fs, a bevy of genes involved in cell cycle progression 3 , many of which are permanently repressed in senescent and SAFA-depleted cells (see Supplementary Fig. 1 ). We thus considered that PANDA could sequester NF-YA from occupying target genes, thus, impeding the expression of NF-YA:E2F-coregulated pro-proliferation targets. To this effect, we first determined the physical presence of NF-YA on selected, cognate E2F targets in pre-senescent (PS), senescent (S), SAFA (siS)-depleted and siControl (siC) cells by qChIP-PCR. ARTICLE Consistent with the idea that PANDA sequesters NF-YA from its targets we found that in senescent (Fig. 7a, right panel) and SAFA-depleted cells (siS) (Fig. 7a , left panel) NF-YA binding to its gene targets including AURKA, CCNB1, CDK1 and CDC25C was severely compromised when compared with respective controls although expression of NF-YA remained unchanged in senescent and siSAFA-treated cells when compared with control cells (Supplementary Fig. 7a ). Importantly, NF-YA presence at promoters could be rescued by overexpression of SAFA in siSAFA-treated cells demonstrating the specificity of the siSAFA treatment ( Supplementary Fig. 7b, compare lanes 8 and 9) . To examine whether or not NF-YA would differentially interact with PANDA in senescent (S) versus pre-senescent proliferating (PS) and siSAFA (siS)-versus siControl (siC)-treated BJ fibroblasts, we performed endogenous RIP analysis using an antibody to NF-YA. As summarized in Fig. 7b and Supplementary Fig. 7c , we found NF-YA to bind to PANDA exclusively in senescent (upper right panel) and SAFA-depleted cells (lower right panel), whereas in the respective control cells, the interaction was barely detectable, the latter also illustrating the specificity of the interaction. There was also no enrichment for abundant HRPT mRNA in the NF-YA pull-downs further confirming the specificity of the PANDA:NF-YA interaction. The exclusive interaction between PANDA and NF-YA in senescent cells was exactly reciprocal to what we had observed for the association between PANDA and SAFA in proliferating cells (see Fig. 5b ). These data thus show that PANDA switches between NF-YA and SAFA complexes in a cell-fate dependent manner. On the basis of these results we inferred that acute PANDA depletion from fully established senescent cells might restore NF-YA function, thus enabling reactivation of a pro-proliferative target gene expression programme and ultimately restoring cell proliferation. Indeed, siRNA-mediated PANDA depletion over a period of 6 days in fully senescent BJ fibroblasts (S þ siP) caused a transient upregulation of pro-proliferation NF-YA:E2F coregulated targets such as PCNA, TK1, MCM3, CDK1, CCNA2, CCNB1 and LB1 and a strong downregulation of pro-senescence PRC target CDKN1A when compared with siControl-treated senescent cells (S þ siC) (Fig. 7c) . The activating effect of NF-YA on the expression of these genes was further supported by the downregulation of their expression in NF-YA-depleted cells ( Supplementary Fig. 7d ). Interestingly, the PANDA and SAFA levels obtained after siRNA-mediated PANDA silencing were comparable to those of siC-treated pre-senescent proliferating cells (PS þ siC) ( Supplementary Fig. 7e ), which may favour the repartioning of PANDA from NF-YA back to SAFA to activate PRC1 function leading to re-repression of pro-senescence PRC targets as exemplified here for CDKN1A. Consistent with the creation of an anti-senescence, pro-proliferative intracellular environment, we observed an B1.5-fold reduction in the number of SABG-positive cells (Fig. 7d) , a B2-fold increase in actively replicating cells as evidenced by an incorporation of 5-ethynyl-2 deoxyuridine (EdU) into DNA (Fig. 7e) as well as a B2-fold increase in cell numbers in PANDA-depleted compared with siC-treated senescent cells, which is comparable to senescent cells treated with sip53 serving as a positive control for senescence escape 49 (Fig. 7f) . To corroborate further the importance of NF-YA for senescence exit, we transiently transfected fully RASsenescent cells with siNF-YA or an NF-YA expression construct (pSG5-NF-YA) either alone or together with siPANDA (siNF-YA/siP and NF-YA/siP). As shown in Fig. 7g ,h and Supplementary Fig. 7f , overexpression of NF-YA led to senescence escape while its silencing caused cell death of senescent cells as indicated by a dramatic loss in cell numbers and cytomorphological changes. Thus, NF-YA is an instrumental factor both for the escape from senescence as well as survival of senescent cells underlining the importance of PANDA as a molecular decoy for the transcription factor NF-YA. Of note, we detected a significant negative correlation between PANDA, CDKN1A and SAFA, BMI1, EZH2 transcript levels in human hepatocellular carcinomas (HCC) when compared with normal liver samples with PANDA and CDKN1A levels significantly reduced (B2-fold) and SAFA (B2-fold), BMI1 (B1.7-fold) and EZH2 (B4.5-fold) levels significantly increased. Importantly, PANDA and CDKN1A downregulation was independent of P53 mutational status in HCC indicating that there is positive selective pressure for low PANDA and CDKN1A and elevated SAFA, BMI1 and EZH2 expression levels. This implies that repressive forces like SAFA-PRC complexes rather than the lack of active forces like p53 may control PANDA and CDKN1A expression in these tumours, which is in line with published results for EZH2-dependent repression of CDKN1A in melanomas 33 ( Supplementary Fig. 7f and Supplementary Table 1 ). Collectively, our results demonstrate that PANDA has a critical role for the establishment and maintenance of the senescence phenotype by facilitating the repression of a proproliferative gene expression programme driven by NF-YA and E2F transcription factors, at least in part, by working as a decoy molecule for NF-YA. Accordingly, a decrease in PANDA levels in fully senescent cells creates a cellular milieu conducive for proliferation including the re-activation of NF-YA:E2F-function and the re-repression of pro-senescence PRC-responsive targets like CDKN1A.
Discussion
Our knowledge about the gene-regulatory mechanisms that govern the onset and maintenance of the senescence phenotype must still be considered fragmentary. We have recently shown that microRNAs (miR) and miR-binding protein argonaute 2 (AGO2) are critical for senescence induction by facilitating transcriptional gene silencing of E2F-regulated proliferationpromoting genes during senescence 5 . We now extend the crucial function of noncoding RNAs (ncRNAs) and RNA-binding proteins (RBPs) in senescence-associated gene regulation to another class of ncRNAs and RBPs. In the present study, we provide compelling evidence for a critical and novel function of scaffold-attachment-factor A (SAFA alias hnRNPU) and lncRNA PANDA in the regulation of proliferation and cellular senescence (Fig. 8) . One major finding is that SAFA and lncRNA PANDA physically and functionally interact to repress senescencepromoting/enforcing genes in proliferating cells by effectively recruiting BMI1-PRC1 and EZH2-PRC2 to promoters of these genes. This is consistent with the role SAFA has in the deposition of the PRC2-catalysed K27 me3 negative chromatin mark in X-inactivation 23 . In senescent cells, SAFA-PANDA-PRC interactions are disrupted and pro-senescence genes are derepressed and congruent with this, acute SAFA and PANDA depletion in pre-senescent proliferating cells equally leads to derepression of these genes and induces a senescence arrest. On the basis of these data, we speculate that in many cases the binding between PRC complexes and lincRNAs and their recruitment to target genes may not be direct but is likely mediated by multimodular DNA/RNA-binding proteins such as SAFA/ hnRNPU or the recently identified hnRNPK 45 . Due to their multimodular nature, these proteins naturally lend themselves to multilateral crosstalk and they are thus able to integrate inputs from different signal transduction pathways and to control outputs. In conclusion, SAFA-PANDA-dependent PRC recruitment and repression of respective response genes entails a combination of self-reinforcing DNA-protein, RNA-protein and protein-protein interactions.
Another major finding of our study is that PANDA changes partners depending on cell fate. PANDA and SAFA predominantly interact in pre-senescent, proliferating cells although PANDA expression is strongly increased in senescent cells. In the latter, PANDA is primarily bound by NF-YA. The reduced association between SAFA and PANDA can be explained, at least in part, by the decrease of SAFA protein levels in senescent cells. Yet, we believe that the changes in affinity are not solely the result of reduced SAFA levels but most likely are also regulated by posttranslational modifications of the two proteins. Indeed, SAFA and NF-YA are subject to different types of posttranslational modifications including phophorylation, acetylation and ubiquitination 50, 51 . In senescent cells, we find that PANDA inhibits the expression of crucial E2F-regulated proliferation-promoting genes by sequestering the transcription factor NF-YA from occupying E2F/NF-YA target gene promoters. PANDA depletion here leads to re-activation of these genes and to senescence exit. This finding underscores the important function of NF-YA in fostering a cooperative interaction with E2F transcription factors to regulate cell cycle genes 3, 4 and also propounds the notion that the ability of E2Fs to functionally interact with a specific promoter element is dictated by the presence of other partner proteins or RNAs as we have previously described for miR-AGO2-mediated transcriptional silencing of E2F target genes 4, 5 . Remarkably, we also find that depletion of NF-YA from fully senescent cells leads to cell death demonstrating a function of NF-YA beyond its regulation of E2F targets in the survival of senescent cells. This is remarkable because senescent cells are inherently resistant to undergo apoptosis 52, 53 . A function for NF-YA in cell death is well documented in mammalian cells, however, only in the context of proliferating cells where NF-YA depletion or overexpression was shown to drive cells towards p53 or E2F1-mediated apoptosis 26, 54 . Thus, our data opens a new line of investigation towards a specific role for NF-YA in survival of senescent cells and this may be of future therapeutical utility to specifically eliminate senescent cells as an accumulation of these cell can have detrimental organismal effects in the long run 55 .
From the above it follows that PANDA may be viewed as a 'locking device' that confines cells in their current proliferative state. Accordingly, in proliferating cells, PANDA depletion causes senescence entry whereas in fully senescent cells PANDA depletion leads to senescence exit. The latter may be exploited by tumours because we observed a significant downregulation of PANDA in HCCs, which was correlated with increased expression levels of SAFA, BMI1 and EZH2, all of which are repressors of PANDA expression.
In summary, we demonstrate that SAFA and PANDA have a crucial role for senescence entry and exit and thus extends the role that PANDA has in cell-fate decisions beyond apoptosis 19 .
While we leave open the possibility that SAFA and PANDA may regulate proliferation and senescence through additional mechanisms, we provide a series of evidence suggesting that modulation of PRC and NF-YA function(s) has a major role in these processes. In addition, our data throw a new light on the role of PcG proteins in fully differentiated cells: their main function here seems to assist in dynamically modulating the expression of genes involved in signalling and proliferation rather than to just maintain epigenetic memory of their silencing.
Methods
Vectors and viruses. Retroviral vector pBABE-RAS V12 and pLNCX Neo -ER:Ras V12 was as reported 5, 24 . To activate ER:Ras V12 , infected cells were treated with 100 nM 4OHT or EtOH as control. Lentiviral shSAFA constructs TRCN0000001297, PANDA recruit PRC2 and BMI1-PRC1 complexes to generate repressive histone marks H3K27 me3 and H2AK119 Ub1 and dampen transcription of prosenescence PRC target genes such as coregulated targets CDKN1A and noncoding transcript PANDA. PANDA acts in an autoregulatory loop with SAFA-BMI1-PRC1 to regulate its own trancription as well as function of the complex. The staggered arrow indicates that low stoichiometric concentrations of certain pro-senescence factors may be beneficial for proliferation as is the case for CDKN1A, which operates as an assembly factor for active cyclin DCdk4/6 complexes 60 . NF-YA affinity for PANDA is low and it thus is free to induce-coactivate with E2F transcription factors, the expression of proliferationpromoting genes. In cells undergoing senescence (right panel of cartoon), SAFA-PRC2 and SAFA-PANDA-BMI1-PRC1 complexes disintegrate and expression of pro-senescence genes including PANDA and CDKN1A is upregulated (depicted here by H4K8-(K8ac) and H3K9-acetylation (K9ac)). PANDA now blocks proliferation by decoying NF-YA. NF-YA is also required for survival of senescent cells. CDKN1A mediates cell cycle arrest by activating tumour suppressor protein Rb, which assembles E2Fs into co-repressor complexes including histone methyl transferases (HMT), histone deacytylases (HDAC) and components of the RNAi machinery to repress expression of proliferation-promoting genes (depicted here by H3K9-trimethylation, K9me) and thus to enforce senescence arrest.
